It is worth noting that the creatinine/cystatin C ratio can perform good prognostic differentiation on rectal cancer (50.8% vs 68.8%, p=0.003) and colon cancer (54.1% vs 69.0%, p=0.009) (Figure S3B, D). This evidence concerns the gene CST3 and colonic neoplasm.